Nobel Biocare further extends its product portfolio at EAO

Search Dental Tribune

Nobel Biocare further extends its product portfolio at EAO

In a live demonstration, Dr Pascal Kunz showed the audience how the DTX Studio Implant empowers the X-Guide for dynamic 3-D navigation. (Photograph: Monique Mehler, DTI)
Dental Tribune International

By Dental Tribune International

Thu. 11. October 2018

save

VIENNA, Austria: At its press conference on Thursday morning, Switzerland-based company Nobel Biocare announced the next step in its digital workflow with a new option for same-day guided surgery made possible by DTX Studio Implant and the X-Guide dental navigation system. In addition, the company is introducing creos mucogain, a resorbable collagen matrix for soft-tissue regeneration, as well as the NobelPro Line, in order to highlight the possibilities of Nobel Biocare’s comprehensive range of edentulous treatment solutions.

With X-Guide, being demonstrated at the fully equipped Nobel Biocare lounge by Dr Pascal Kunz, clinicians have a new treatment option for same-day surgery. DTX Studio Implant empowers this innovative system for dynamic 3-D navigation. With the software officially being launched for European markets at the EAO congress, treatment plans from DTX Studio Implant (formerly NobelClinician) can now be instantly delivered to the patient, providing a workflow for diagnostics, implant planning and dynamically navigated implant surgeries, even during emergency interventions where computer-assisted surgeries until now could not be fully applied.

Using DTX Studio Implant and X-Guide, clinicians can achieve high-precision, shorter time-to-teeth treatments, including screw-retained provisionalisation with full 3-D control of their implant site preparation and dynamically monitored implant insertion. The procedure only takes minutes from the CBCT scanning to the start of the surgery. Similar to a GPS in a car, X-Guide provides stable, lag-free, real-time 3-D intra-oral guidance of the drill and implant position in relation to patient anatomy. X-Guide is manufactured by X-Nav Technologies, a North America-based innovator in dental 3-D navigation who has exclusively partnered with Nobel Biocare.

Extending Nobel Biocare’s range of solutions for guided bone and tissue regeneration, the new creos mucogain resorbable collagen matrix is intended to be used as an alternative for autologous soft-tissue grafts in various soft-tissue indications, such as soft-tissue volume augmentation and root coverage in submerged healing. Composed of highly purified porcine collagen and elastin fibres, it has an open interconnecting porous structure designed to promote soft-tissue regeneration through the migration of cells and blood vessels into the matrix.1, 2

The matrix offers high stress resistance and suture retention2 that is sufficient for the tunnelling technique.3 Owing to a memory effect, it retains its initial volume when hydrated.2 Creos mucogain is available in different sizes (15 × 20 mm and 25 × 30 mm) and thicknesses (3 and 5 mm). According to Nobel Biocare, it offers excellent handling, as it can be used directly out of the packaging and trimmed to precisely fit the surgical site.3

Highlighting its range of edentulous treatment solutions, Nobel Biocare is further announcing the NobelPro Line to showcase the benefits of immediate function, along with the latest advancements in minimally invasive care. With an assortment of clinically successful and proven treatment options, including NobelSpeedy and NobelZygoma, clinicians can take the All-on-4 treatment concept to new heights and treat even the most challenging maxillary cases with moderate up to severe resorption.

At the press conference, President of Nobel Biocare Hans Geiselhöringer said, “Nobel Biocare has once again shown that it is a leading force in bringing cutting-edge technology and solutions to clinicians worldwide. With the addition of dynamic navigation to its digital workflow, Nobel Biocare looks forward to helping more clinicians leverage the latest in implant treatment technology. Together with forward-looking regenerative solutions like creos mucogain as well as the NobelPro Line, they now have better treatment options available to lead more patients to immediate function and excellent aesthetics.”

Clinical insights on X-Guide, creos mucogain and the NobelPro Line will be given during clinical lectures and hands-on courses presented by Nobel Biocare in Vienna. More information is available at Booth D02 and online at http://www.nobelbiocare.com/eao.

References

  1. Boekema BK, Vlig M, Olde Damink L, Middelkoop E, Eummelen L, Bühren AV, Ulrich MM. Effect of pore size and cross-linking of a novel collagen-elastin dermal substitute on wound healing. J Mater Sci Mater Med. 2014 Feb;25(2):423–33.
  2. Olde Damink L, Heschel I, Leemhuis H, Tortorici M, Wessing B. Soft tissue volume augmentation in the oral cavity with a collagen-based 3D matrix with orientated open pore structure. CDBME. 2018 Sep;4(1):237–41.
  3. Wessing B, Vasilic N. Soft tissue augmentation with a new regenerative collagen 3-D matrix with oriented open pores as a potential alternative to autologous connective tissue grafts. Clin Oral Implants Res. 2014;25(10 Suppl):342. Available from: dentalcongressposters.com/eao2014/wessing.pdf.

Congress EAO Launch Nobel Biocare Portfolio Product

Leave a Reply

Your email address will not be published. Required fields are marked *

advertisement
advertisement